166 related articles for article (PubMed ID: 7834827)
1. c-myc in vasculoproliferative disease.
Edelman ER; Simons M; Sirois MG; Rosenberg RD
Circ Res; 1995 Feb; 76(2):176-82. PubMed ID: 7834827
[TBL] [Abstract][Full Text] [Related]
2. Effects of antisense c-myb oligonucleotides on vascular smooth muscle cell proliferation and response to vessel wall injury.
Villa AE; Guzman LA; Poptic EJ; Labhasetwar V; D'Souza S; Farrell CL; Plow EF; Levy RJ; DiCorleto PE; Topol EJ
Circ Res; 1995 Apr; 76(4):505-13. PubMed ID: 7895327
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides.
Bennett MR; Anglin S; McEwan JR; Jagoe R; Newby AC; Evan GI
J Clin Invest; 1994 Feb; 93(2):820-8. PubMed ID: 8113414
[TBL] [Abstract][Full Text] [Related]
4. Effect of phosphorothioated oligonucleotides on neointima formation in the rat carotid artery. Dissecting the mechanism of action.
Bennett MR; Lindner V; DeBlois D; Reidy MA; Schwartz SM
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2326-32. PubMed ID: 9409198
[TBL] [Abstract][Full Text] [Related]
5. Mithramycin inhibits myointimal proliferation after balloon injury of the rat carotid artery in vivo.
Chen SJ; Chen YF; Miller DM; Li H; Oparil S
Circulation; 1994 Nov; 90(5):2468-73. PubMed ID: 7955204
[TBL] [Abstract][Full Text] [Related]
6. The activity of c-myb antisense oligonucleotide to prevent intimal hyperplasia is nonspecific.
Castier Y; Chemla E; Nierat J; Heudes D; Vasseur MA; Rajnoch C; Bruneval P; Carpentier A; Fabiani JN
J Cardiovasc Surg (Torino); 1998 Feb; 39(1):1-7. PubMed ID: 9537527
[TBL] [Abstract][Full Text] [Related]
7. Transcatheter delivery of c-myc antisense oligomers reduces neointimal formation in a porcine model of coronary artery balloon injury.
Shi Y; Fard A; Galeo A; Hutchinson HG; Vermani P; Dodge GR; Hall DJ; Shaheen F; Zalewski A
Circulation; 1994 Aug; 90(2):944-51. PubMed ID: 8044966
[TBL] [Abstract][Full Text] [Related]
8. The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism.
Burgess TL; Fisher EF; Ross SL; Bready JV; Qian YX; Bayewitch LA; Cohen AM; Herrera CJ; Hu SS; Kramer TB
Proc Natl Acad Sci U S A; 1995 Apr; 92(9):4051-5. PubMed ID: 7732029
[TBL] [Abstract][Full Text] [Related]
9. Intimal hyperplasia following vascular injury is not inhibited by an antisense thrombin receptor oligodeoxynucleotide.
Herbert JM; Guy AF; Lamarche I; Mares AM; Savi P; Dol F
J Cell Physiol; 1997 Feb; 170(2):106-14. PubMed ID: 9009139
[TBL] [Abstract][Full Text] [Related]
10. Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia.
Morishita R; Gibbons GH; Ellison KE; Nakajima M; Zhang L; Kaneda Y; Ogihara T; Dzau VJ
Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8474-8. PubMed ID: 8104336
[TBL] [Abstract][Full Text] [Related]
11. Antiproliferative effects of a c-myc antisense oligonucleotide on human arterial smooth muscle cells.
Ebbecke M; Unterberg C; Buchwald A; Stöhr S; Wiegand V
Basic Res Cardiol; 1992; 87(6):585-91. PubMed ID: 1485890
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of c-myc expression by antisense oligonucleotides inhibits proliferation of human smooth muscle cells.
Shi Y; Hutchinson HG; Hall DJ; Zalewski A
Circulation; 1993 Sep; 88(3):1190-5. PubMed ID: 8353880
[TBL] [Abstract][Full Text] [Related]
13. [Effects of an anti-c-myb antisense oligonucleotide on myo-intimal proliferation. Specificity of action and consequences on vasoreactivity].
Castier Y; Chemla E; Chardigny C; Nierat J; Eudes D; Vasseur MA; Bruneval P; Carpentier A; Fabiani JN
Arch Mal Coeur Vaiss; 1996 Jul; 89(7):889-96. PubMed ID: 8869251
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of smooth muscle cell proliferation and migration in vitro by antisense oligonucleotide to c-myb.
Pitsch RJ; Goodman GR; Minion DJ; Madura JA; Fox PL; Graham LM
J Vasc Surg; 1996 May; 23(5):783-91. PubMed ID: 8667499
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration.
Biro S; Fu YM; Yu ZX; Epstein SE
Proc Natl Acad Sci U S A; 1993 Jan; 90(2):654-8. PubMed ID: 8421701
[TBL] [Abstract][Full Text] [Related]
16. Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery injury model.
Simons M; Edelman ER; Rosenberg RD
J Clin Invest; 1994 Jun; 93(6):2351-6. PubMed ID: 7911126
[TBL] [Abstract][Full Text] [Related]
17. [The inhibitory effect of antisense phosphorothioate c-myc oligodeoxynucleotide on intimal hyperplasia in rat abdominal aortae after injury with a balloon catheter].
Wang J; Hu D; Liu K
Zhonghua Yi Xue Za Zhi; 1998 May; 78(5):388-91. PubMed ID: 10923448
[TBL] [Abstract][Full Text] [Related]
18. [Effect of antisense oligonucleotides on myo-intimal hyperplasia in a model of abdominal aortic injury in the rat].
Chemla E; Julia P; Nierat J; Eudes D; Bruneval P; Carpentier A; Fabiani JN
Arch Mal Coeur Vaiss; 1995 Mar; 88(3):381-9. PubMed ID: 7487292
[TBL] [Abstract][Full Text] [Related]
19. Contribution of sequence and phosphorothioate content to inhibition of cell growth and adhesion caused by c-myc antisense oligomers.
Chavany C; Connell Y; Neckers L
Mol Pharmacol; 1995 Oct; 48(4):738-46. PubMed ID: 7476902
[TBL] [Abstract][Full Text] [Related]
20. [Inhibitory effects of antisense oligonucleotides delivered locally via hydrogel catheter on myointimal hyperplasia of rat carotid artery after nitrogen drying].
Xi Y; Wang L; Zhu G
Zhonghua Yi Xue Za Zhi; 1996 Feb; 76(2):109-11. PubMed ID: 8758441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]